Skip to content

What is PTA for peripheral arterial disease?

Percutaneous transluminal angioplasty (PTA) refers to the use of catheter-based interventions to treat impaired blood flow in the limbs.

In addition to using balloons to dilate narrowed blood vessels, PTA can also include the use of drug-eluting balloons, endovascular stents, and drug-eluting stents. PTA may also involve the use of lasers, aspirators and drills, although this is much less common.

Historical origins and development

Charles T. Dotter and Melvin P. Judkins fathered PTA when they first used a catheter to widen a stenotic blood vessel in 1964.

This technology has undergone - and continues to undergo - considerable developments, and is now regarded as the first-line treatment in patients with peripheral arterial disease (PAD).

What is the purpose of this type of treatment, and what are the results?

One of the basic tenets of PAD treatment is the management of risk factors such as smoking, diabetes, high blood pressure and abnormalities in lipid metabolism.

Although the use of supervised walking programs and medication have proved successful in the treatment of PAD, a catheter-based intervention may be advised in cases where these measures do not achieve sufficient improvements in symptoms or the distance a patient can walk before developing pain.

If the site(s) and extent of the stenosis are such that PTA is unlikely to be successful, bypass surgery should be considered.


Web links

Deutsche Gesellschaft für Gefäßmedizin (German Society of Angiology, DGA)

www.dga-online.org

Leitlinien zur Diagnostik und Therapie der peripheren arteriellen Verschlusskrankheit [guidelines on the diagnosis and treatment of peripheral arterial disease]

http://www.dga-gefaessmedizin.de/uploads/media/

TO PERIPHERAL VASCULAR SURGERY